98%
921
2 minutes
20
Microglia, the resident macrophages of the central nervous system, exhibit altered gene expression in response to various neurological conditions. This study investigates the relationship between West Nile Virus infection and microglial senescence, focusing on the role of LGALS3BP, a protein implicated in both antiviral responses and aging. Using spatial transcriptomics, RNA sequencing and flow cytometry, we characterized changes in microglial gene signatures in adult and aged mice following recovery from WNV encephalitis. Additionally, we analyzed expression and generated -deficient mice to assess the impact on neuroinflammation and microglial phenotypes. Our results show that WNV-activated microglia share transcriptional signatures with aged microglia, including upregulation of genes involved in interferon response and inflammation. was broadly expressed in the CNS and robustly upregulated during WNV infection and aging. -deficient mice exhibited reduced neuroinflammation, increased homeostatic microglial numbers, and altered T cell populations without differences in virologic control or survival. These data indicate that LGALS3BP has a role in regulating neuroinflammation and microglial activation and suggest that targeting LGALS3BP might provide a potential route for mitigating neuroinflammation-related cognitive decline in aging and post-viral infections.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11274721 | PMC |
http://dx.doi.org/10.3390/biom14070808 | DOI Listing |
Eye (Lond)
September 2025
Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Objectives: To characterise the chorioretinal (CR) manifestations of West Nile virus (WNV) infection using multimodal imaging (MMI).
Methods: Retrospective cohort study including 37 patients with confirmed WNV infection hospitalised at a single centre (July-September 2024). All underwent comprehensive ophthalmological evaluations, including visual acuity, slit-lamp biomicroscopy, fundoscopy, and multimodal imaging: fundus photography, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), fluorescein angiography, and indocyanine green angiography when clinically indicated.
J Virol
September 2025
Laboratory of Virology, Wageningen University & Research, Wageningen, the Netherlands.
Vertebrate animals and many small DNA and single-stranded RNA viruses that infect vertebrates have evolved to suppress genomic CpG dinucleotides. All organisms and most viruses additionally suppress UpA dinucleotides in protein-coding RNA. Synonymously recoding viral genomes to introduce CpG or UpA dinucleotides has emerged as an approach for viral attenuation and vaccine development.
View Article and Find Full Text PDFOne Health
December 2025
Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Introduction: Climate variability and non-environmental factors such as travel and migration pose an increasing risk of vector-borne infectious diseases to extratropical regions. The European Centre for Disease Prevention and Control has reported autochthonous transmissions of dengue or West Nile virus in Italy, France, Spain, and Germany. Raising awareness and implementing protective measures against mosquitoes will therefore become increasingly relevant in Germany in the future.
View Article and Find Full Text PDFJ Food Prot
September 2025
Faculty of Veterinary Medicine, Hawassa University, Hawassa Ethiopia, P.O.Box. 05.
Escherichia coli O157:H7 is a significant foodborne pathogen with global public health implications. This study, conducted from December 2022 to July 2023 in Hawassa and Yirgalem, Sidama Region, Ethiopia, assessed the prevalence, molecular identification, and antimicrobial resistance of E. coli O157:H7 in animal-derived foods.
View Article and Find Full Text PDFInt J Infect Dis
September 2025
Division of Infection and Immunity, University College London, London, United Kingdom; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, NW3 OPQ, United Kingdom. Electronic address: